Trimethoprim, Sulfamethoxazole Drug Combination
"Trimethoprim, Sulfamethoxazole Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
| Descriptor ID |
D015662
|
| MeSH Number(s) |
D02.065.884.725.867.500 D02.092.146.807.867.500 D02.886.590.700.725.867.500 D03.383.742.906.500 D26.310.875
|
| Concept/Terms |
Trimethoprim, Sulfamethoxazole Drug Combination- Trimethoprim, Sulfamethoxazole Drug Combination
- Centrin
- Cotrimoxazole
- Eslectin
- Insozalin
- TMP-SMX
- Trimethoprim-Sulfamethoxazole
- Trimethoprim Sulfamethoxazole
- Sulfamethoxazole-Trimethoprim Combination
- Sulfamethoxazole Trimethoprim Combination
- Trimethoprim-Sulfamethoxazole Combination
- Trimethoprim Sulfamethoxazole Combination
- Trimezole
- Co-Trimoxazole
- Co Trimoxazole
- TMP SMX
- Centran
- Trimedin
|
Below are MeSH descriptors whose meaning is more general than "Trimethoprim, Sulfamethoxazole Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Trimethoprim, Sulfamethoxazole Drug Combination".
This graph shows the total number of publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in this website by year, and whether "Trimethoprim, Sulfamethoxazole Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trimethoprim, Sulfamethoxazole Drug Combination" by people in Profiles.
-
Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
-
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients. BMC Pulm Med. 2018 Feb 14; 18(1):35.
-
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. Antimicrob Agents Chemother. 2018 01; 62(1).
-
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics. Antimicrob Agents Chemother. 2016 05; 60(5):3138-40.
-
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots. Bioanalysis. 2015; 7(9):1137-49.
-
Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis. Curr Rheumatol Rep. 2014 Oct; 16(10):445.
-
Salmonella-related urinary tract infection in an elderly patient. BMJ Case Rep. 2014 Sep 05; 2014.
-
Methicillin-resistant Staphylococcus aureus as a common cause of vulvar abscesses. Obstet Gynecol. 2008 Sep; 112(3):538-44.
-
Role of interval appendectomy in the management of complicated appendicitis in children. World J Surg. 2006 Jan; 30(1):51-4.
-
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology. 2004 Oct; 64(4):808-10.